{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T02:18:44Z","timestamp":1772245124786,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171858"],"award-info":[{"award-number":["82171858"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Research and Development Program of China National Railway Group Co., Ltd","award":["K2019Z005"],"award-info":[{"award-number":["K2019Z005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81226-z","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T16:54:25Z","timestamp":1733331265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of intermittent hypoxic training combined with methazolamide in the prevention of high-altitude cerebral edema in rats"],"prefix":"10.1038","volume":"14","author":[{"given":"Weicheng","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"81226_CR1","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1164\/rccm.201108-1396OC","volume":"185","author":"J-P Richalet","year":"2012","unstructured":"Richalet, J.-P., Larmignat, P., Poitrine, E., Letournel, M. & Canou\u00ef-Poitrine, F. Physiological risk factors for severe high-altitude illness: a prospective cohort study. Am J Respir Crit Care Med 185, 192\u2013198. https:\/\/doi.org\/10.1164\/rccm.201108-1396OC (2012).","journal-title":"Am J Respir Crit Care Med"},{"key":"81226_CR2","doi-asserted-by":"crossref","unstructured":"Gallagher, S. A. & Hackett, P. H. High-altitude illness. Emerg Med Clin North Am 22 (2004).","DOI":"10.1016\/j.emc.2004.02.001"},{"key":"81226_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1474-4422(09)70014-6","volume":"8","author":"MH Wilson","year":"2009","unstructured":"Wilson, M. H., Newman, S. & Imray, C. H. The cerebral effects of ascent to high altitudes. Lancet Neurol 8, 175\u2013191. https:\/\/doi.org\/10.1016\/S1474-4422(09)70014-6 (2009).","journal-title":"Lancet Neurol"},{"key":"81226_CR4","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMcp1214870","volume":"368","author":"P B\u00e4rtsch","year":"2013","unstructured":"B\u00e4rtsch, P. & Swenson, E. R. Clinical practice: Acute high-altitude illnesses. N Engl J Med 368, 2294\u20132302. https:\/\/doi.org\/10.1056\/NEJMcp1214870 (2013).","journal-title":"N Engl J Med"},{"key":"81226_CR5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/jtm.12017","volume":"20","author":"N Netzer","year":"2013","unstructured":"Netzer, N., Strohl, K., Faulhaber, M., Gatterer, H. & Burtscher, M. Hypoxia-related altitude illnesses. J Travel Med 20, 247\u2013255. https:\/\/doi.org\/10.1111\/jtm.12017 (2013).","journal-title":"J Travel Med"},{"key":"81226_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1089\/ham.2010.1030","volume":"11","author":"MJ MacInnis","year":"2010","unstructured":"MacInnis, M. J., Koehle, M. S. & Rupert, J. L. Evidence for a genetic basis for altitude illness: 2010 update. High Alt Med Biol 11, 349\u2013368. https:\/\/doi.org\/10.1089\/ham.2010.1030 (2010).","journal-title":"High Alt Med Biol"},{"key":"81226_CR7","doi-asserted-by":"publisher","unstructured":"Derby, R. & deWeber, K. The athlete and high altitude. Curr Sports Med Rep 9, 79\u201385, https:\/\/doi.org\/10.1249\/JSR.0b013e3181d404ac (2010).","DOI":"10.1249\/JSR.0b013e3181d404ac"},{"key":"81226_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1089\/1527029041352054","volume":"5","author":"PH Hackett","year":"2004","unstructured":"Hackett, P. H. & Roach, R. C. High altitude cerebral edema. High Alt Med Biol 5, 136\u2013146 (2004).","journal-title":"High Alt Med Biol"},{"key":"81226_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.tjem.2019.09.002","volume":"19","author":"G Aksel","year":"2019","unstructured":"Aksel, G., \u00c7orbac\u0131o\u011flu, \u015eK. & \u00d6zen, C. High-altitude illness: Management approach. Turk J Emerg Med 19, 121\u2013126. https:\/\/doi.org\/10.1016\/j.tjem.2019.09.002 (2019).","journal-title":"Turk J Emerg Med"},{"key":"81226_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/biologics2010007","volume":"2","author":"R Zelmanovich","year":"2022","unstructured":"Zelmanovich, R. et al. High Altitude Cerebral Edema: Improving Treatment Options. Biologics 2, 81\u201391 (2022).","journal-title":"Biologics"},{"key":"81226_CR11","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1212\/WNL.0000000000004544","volume":"89","author":"VHR Marussi","year":"2017","unstructured":"Marussi, V. H. R. et al. Teaching NeuroImages: Typical neuroimaging features in high-altitude cerebral edema. Neurology 89, e176\u2013e177. https:\/\/doi.org\/10.1212\/WNL.0000000000004544 (2017).","journal-title":"Neurology"},{"key":"81226_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00424-023-02885-x","volume":"476","author":"G Zhang","year":"2024","unstructured":"Zhang, G. et al. Intermittent hypoxia training effectively protects against cognitive decline caused by acute hypoxia exposure. Pflugers Arch 476, 197\u2013210. https:\/\/doi.org\/10.1007\/s00424-023-02885-x (2024).","journal-title":"Pflugers Arch"},{"key":"81226_CR13","doi-asserted-by":"publisher","first-page":"R1181","DOI":"10.1152\/ajpregu.00208.2014","volume":"307","author":"A Navarrete-Opazo","year":"2014","unstructured":"Navarrete-Opazo, A. & Mitchell, G. S. Therapeutic potential of intermittent hypoxia: a matter of dose. Am J Physiol Regul Integr Comp Physiol 307, R1181\u2013R1197. https:\/\/doi.org\/10.1152\/ajpregu.00208.2014 (2014).","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"81226_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14662","volume":"30","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Intermittent hypoxia preconditioning can attenuate acute hypoxic injury after a sustained normobaric hypoxic exposure: A randomized clinical trial. CNS Neurosci Ther 30, e14662. https:\/\/doi.org\/10.1111\/cns.14662 (2024).","journal-title":"CNS Neurosci Ther"},{"key":"81226_CR15","doi-asserted-by":"publisher","unstructured":"Doherty, C. J. et al. The Impact of Acetazolamide and Methazolamide on Exercise Performance in Normoxia and Hypoxia. High Alt Med Biol 24, https:\/\/doi.org\/10.1089\/ham.2022.0134 (2023).","DOI":"10.1089\/ham.2022.0134"},{"key":"81226_CR16","doi-asserted-by":"publisher","DOI":"10.5867\/medwave.2019.11.7736","volume":"19","author":"L Tapia","year":"2019","unstructured":"Tapia, L. & Irarr\u00e1zaval, S. Acetazolamide for the treatment of acute mountain sickness. Medwave 19, e7737. https:\/\/doi.org\/10.5867\/medwave.2019.11.7736 (2019).","journal-title":"Medwave"},{"key":"81226_CR17","doi-asserted-by":"publisher","unstructured":"Simancas-Racines, D. et al. Interventions for treating acute high altitude illness. Cochrane Database Syst Rev 6, CD009567, https:\/\/doi.org\/10.1002\/14651858.CD009567.pub2 (2018).","DOI":"10.1002\/14651858.CD009567.pub2"},{"key":"81226_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/07853890.2017.1407034","volume":"50","author":"K Sridharan","year":"2018","unstructured":"Sridharan, K. & Sivaramakrishnan, G. Pharmacological interventions for preventing acute mountain sickness: a network meta-analysis and trial sequential analysis of randomized clinical trials. Ann Med 50, 147\u2013155. https:\/\/doi.org\/10.1080\/07853890.2017.1407034 (2018).","journal-title":"Ann Med"},{"key":"81226_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2153","volume":"361","author":"J Williamson","year":"2018","unstructured":"Williamson, J., Oakeshott, P. & Dallimore, J. Altitude sickness and acetazolamide. BMJ 361, k2153. https:\/\/doi.org\/10.1136\/bmj.k2153 (2018).","journal-title":"BMJ"},{"key":"81226_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/ham.2017.0044","volume":"19","author":"Z Zhang","year":"2018","unstructured":"Zhang, Z. et al. Therapeutic Efficacy of Methazolamide Against Intermittent Hypoxia-Induced Excessive Erythrocytosis in Rats. High Alt Med Biol 19, 69\u201380. https:\/\/doi.org\/10.1089\/ham.2017.0044 (2018).","journal-title":"High Alt Med Biol"},{"key":"81226_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1517\/14656566.9.1.119","volume":"9","author":"A Wright","year":"2008","unstructured":"Wright, A., Brearey, S. & Imray, C. High hopes at high altitudes: pharmacotherapy for acute mountain sickness and high-altitude cerebral and pulmonary oedema. Expert Opin Pharmacother 9, 119\u2013127 (2008).","journal-title":"Expert Opin Pharmacother"},{"issue":"41","key":"81226_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.16016\/j.1000-5404.201707166","volume":"40","author":"G Xu","year":"2018","unstructured":"Xu, G. Efficiency of methazolamide for hypoxia tolerance in mice and its prevention for acute mountain sickness. Journal of Third Military Medical University (Chinese) 40(41), 12\u201316. https:\/\/doi.org\/10.16016\/j.1000-5404.201707166 (2018).","journal-title":"Journal of Third Military Medical University (Chinese)"},{"key":"81226_CR23","first-page":"619","volume":"54","author":"AD Wright","year":"1983","unstructured":"Wright, A. D., Bradwell, A. R. & Fletcher, R. F. Methazolamide and acetazolamide in acute mountain sickness. Aviat Space Environ Med 54, 619\u2013621 (1983).","journal-title":"Aviat Space Environ Med"},{"key":"81226_CR24","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1080\/14656566.2018.1528228","volume":"19","author":"KE Joyce","year":"2018","unstructured":"Joyce, K. E., Lucas, S. J. E., Imray, C. H. E., Balanos, G. M. & Wright, A. D. Advances in the available non-biological pharmacotherapy prevention and treatment of acute mountain sickness and high altitude cerebral and pulmonary oedema. Expert Opin Pharmacother 19, 1891\u20131902. https:\/\/doi.org\/10.1080\/14656566.2018.1528228 (2018).","journal-title":"Expert Opin Pharmacother"},{"key":"81226_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12974-016-0528-4","volume":"13","author":"T-T Song","year":"2016","unstructured":"Song, T.-T. et al. Systemic pro-inflammatory response facilitates the development of cerebral edema during short hypoxia. J Neuroinflammation 13, 63. https:\/\/doi.org\/10.1186\/s12974-016-0528-4 (2016).","journal-title":"J Neuroinflammation"},{"key":"81226_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neulet.2013.05.008","volume":"547","author":"P Guo","year":"2013","unstructured":"Guo, P., Luo, H., Fan, Y., Luo, Y. & Zhou, Q. Establishment and evaluation of an experimental animal model of high altitude cerebral edema. Neurosci Lett 547, 82\u201386. https:\/\/doi.org\/10.1016\/j.neulet.2013.05.008 (2013).","journal-title":"Neurosci Lett"},{"key":"81226_CR27","doi-asserted-by":"publisher","first-page":"13199","DOI":"10.1073\/pnas.1404493111","volume":"111","author":"S-J Chen","year":"2014","unstructured":"Chen, S.-J. et al. Overactivation of corticotropin-releasing factor receptor type 1 and aquaporin-4 by hypoxia induces cerebral edema. Proc Natl Acad Sci U S A 111, 13199\u201313204. https:\/\/doi.org\/10.1073\/pnas.1404493111 (2014).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"81226_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.brainresbull.2020.10.017","volume":"165","author":"L Jing","year":"2020","unstructured":"Jing, L., Wu, N., He, L., Shao, J. & Ma, H. Establishment of an experimental rat model of high altitude cerebral edema by hypobaric hypoxia combined with temperature fluctuation. Brain Res Bull 165, 253\u2013262. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.10.017 (2020).","journal-title":"Brain Res Bull"},{"key":"81226_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygeno.2022.110519","volume":"114","author":"Y Peng","year":"2022","unstructured":"Peng, Y., Yin, H., Li, S. & Yang, H. Transcriptome of pituitary function changes in rat model of high altitude cerebral edema. Genomics 114, 110519. https:\/\/doi.org\/10.1016\/j.ygeno.2022.110519 (2022).","journal-title":"Genomics"},{"key":"81226_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27833","volume":"10","author":"B Ma","year":"2024","unstructured":"Ma, B. et al. Effect of butylphthalide on prevention and treatment of high altitude cerebral edema in rats. Heliyon 10, e27833. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27833 (2024).","journal-title":"Heliyon"},{"key":"81226_CR31","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1093\/brain\/awf257","volume":"125","author":"HJ Schoch","year":"2002","unstructured":"Schoch, H. J., Fischer, S. & Marti, H. H. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 125, 2549\u20132557 (2002).","journal-title":"Brain"},{"key":"81226_CR32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.lfs.2017.10.021","volume":"193","author":"C Wang","year":"2018","unstructured":"Wang, C. et al. Mechanism of aquaporin 4 (AQP 4) up-regulation in rat cerebral edema under hypobaric hypoxia and the preventative effect of puerarin. Life Sciences 193, 270\u2013281. https:\/\/doi.org\/10.1016\/j.lfs.2017.10.021 (2018).","journal-title":"Life Sciences"},{"key":"81226_CR33","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/jnr.23407","volume":"92","author":"PA Ameli","year":"2014","unstructured":"Ameli, P. A. et al. Role of vasopressin and its antagonism in stroke related edema. Journal of Neuroscience Research 92, 1091\u20131099. https:\/\/doi.org\/10.1002\/jnr.23407 (2014).","journal-title":"Journal of Neuroscience Research"},{"key":"81226_CR34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.intimp.2016.09.010","volume":"40","author":"C Wang","year":"2016","unstructured":"Wang, C. et al. Protective effects of puerarin on acute lung and cerebrum injury induced by hypobaric hypoxia via the regulation of aquaporin (AQP) via NF-\u03baB signaling pathway. Int Immunopharmacol 40, 300\u2013309. https:\/\/doi.org\/10.1016\/j.intimp.2016.09.010 (2016).","journal-title":"Int Immunopharmacol"},{"key":"81226_CR35","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/1742-2094-9-279","volume":"9","author":"AM Fukuda","year":"2012","unstructured":"Fukuda, A. M. & Badaut, J. Aquaporin 4: a player in cerebral edema and neuroinflammation. J Neuroinflammation 9, 279. https:\/\/doi.org\/10.1186\/1742-2094-9-279 (2012).","journal-title":"J Neuroinflammation"},{"key":"81226_CR36","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.intimp.2015.07.008","volume":"28","author":"KP Mishra","year":"2015","unstructured":"Mishra, K. P., Ganju, L. & Singh, S. B. Hypoxia modulates innate immune factors: A review. Int Immunopharmacol 28, 425\u2013428. https:\/\/doi.org\/10.1016\/j.intimp.2015.07.008 (2015).","journal-title":"Int Immunopharmacol"},{"key":"81226_CR37","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jneumeth.2015.02.004","volume":"245","author":"X Huang","year":"2015","unstructured":"Huang, X. et al. A method for establishing the high-altitude cerebral edema (HACE) model by acute hypobaric hypoxia in adult mice. J Neurosci Methods 245, 178\u2013181. https:\/\/doi.org\/10.1016\/j.jneumeth.2015.02.004 (2015).","journal-title":"J Neurosci Methods"},{"key":"81226_CR38","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1089\/ham.2010.1086","volume":"12","author":"TV Serebrovskaya","year":"2011","unstructured":"Serebrovskaya, T. V., Nikolsky, I. S., Nikolska, V. V., Mallet, R. T. & Ishchuk, V. A. Intermittent hypoxia mobilizes hematopoietic progenitors and augments cellular and humoral elements of innate immunity in adult men. High Alt Med Biol 12, 243\u2013252. https:\/\/doi.org\/10.1089\/ham.2010.1086 (2011).","journal-title":"High Alt Med Biol"},{"issue":"120","key":"81226_CR39","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1152\/japplphysiol.00443.2015","volume":"1985","author":"ER Swenson","year":"2016","unstructured":"Swenson, E. R. Pharmacology of acute mountain sickness: old drugs and newer thinking. J Appl Physiol 1985(120), 204\u2013215. https:\/\/doi.org\/10.1152\/japplphysiol.00443.2015 (2016).","journal-title":"J Appl Physiol"},{"issue":"75","key":"81226_CR40","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1152\/jappl.1993.75.4.1587","volume":"1985","author":"R Iturriaga","year":"1993","unstructured":"Iturriaga, R., Mokashi, A. & Lahiri, S. Dynamics of carotid body responses in vitro in the presence of CO2-HCO3-: role of carbonic anhydrase. J Appl Physiol 1985(75), 1587\u20131594 (1993).","journal-title":"J Appl Physiol"},{"key":"81226_CR41","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/978-94-007-7359-2_18","volume":"75","author":"ER Swenson","year":"2014","unstructured":"Swenson, E. R. Carbonic anhydrase inhibitors and high altitude illnesses. Subcell Biochem 75, 361\u2013386. https:\/\/doi.org\/10.1007\/978-94-007-7359-2_18 (2014).","journal-title":"Subcell Biochem"},{"key":"81226_CR42","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.freeradbiomed.2013.05.024","volume":"63","author":"C Lisk","year":"2013","unstructured":"Lisk, C. et al. Nrf2 activation: a potential strategy for the prevention of acute mountain sickness. Free Radic Biol Med 63, 264\u2013273. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.05.024 (2013).","journal-title":"Free Radic Biol Med"},{"key":"81226_CR43","first-page":"162","volume":"71","author":"CS Fulco","year":"2000","unstructured":"Fulco, C. S., Rock, P. B. & Cymerman, A. Improving athletic performance: is altitude residence or altitude training helpful?. Aviat Space Environ Med 71, 162\u2013171 (2000).","journal-title":"Aviat Space Environ Med"},{"key":"81226_CR44","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1089\/ham.2013.1134","volume":"15","author":"P Siques","year":"2014","unstructured":"Siques, P. et al. Plasma and liver lipid profiles in rats exposed to chronic hypobaric hypoxia: changes in metabolic pathways. High Alt Med Biol 15, 388\u2013395. https:\/\/doi.org\/10.1089\/ham.2013.1134 (2014).","journal-title":"High Alt Med Biol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81226-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81226-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81226-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T17:03:28Z","timestamp":1733331808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81226-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["81226"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81226-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]},"assertion":[{"value":"30 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board of Beijing Shijitan Hospital, Capital Medical University, Approval No: sjtkyll-lx-2023(010). This study is reported in accordance with ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"30252"}}